Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fludarabine Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Hunter Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Maroteaux-Lamy Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Mucopolysaccharidosis	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Peroxisomal Disorders	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Sly Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Sphingolipidoses	Masonic Cancer Center, University of Minnesota	P2	B (57)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Aplastic Anemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Krabbe Disease	Masonic Cancer Center, University of Minnesota	P2	B (57)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Metachromatic Leukodystrophy	Masonic Cancer Center, University of Minnesota	P2	B (57)
Monomethyl Fumarate Myelodysplastic Syndrome With Excess Blasts-1	Masonic Cancer Center, University of Minnesota	P2	B (57)
Monomethyl Fumarate Plasma Cell Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
n-803 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
Rapamycin Plasma Cell Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
TACROLIMUS Lymphoplasmacytic Lymphoma	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Fallopian Tube Cancer	Masonic Cancer Center, University of Minnesota	P2	B (56)
Romidepsin Hematopoietic And Lymphoid Cell Neoplasm	Masonic Cancer Center, University of Minnesota	P2	CCC (55)
Treosulfan Acute Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (55)
Allopurinol Plasma Cell Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
Anti-Thymoglobulin, Rabbit Sickle Cell Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
Busulphan Minimal Residual Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
Busulphan Plasma Cell Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Minimal Residual Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
Romidepsin Minimal Residual Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
Treg Cells Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (54)

Showing 126 to 150 of 705 assets

PreviousPage 6 of 29Next